- Home
- SGC vs NKTR Comparison
SGC vs NKTR Comparison
Compare SGC & NKTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SGC
- NKTR
- Stock Information
- Founded
- SGC 1920
- NKTR 1990
- Country
- SGC United States
- NKTR United States
- Employees
- SGC N/A
- NKTR 61
- Industry
- SGC Apparel
- NKTR Biotechnology: Pharmaceutical Preparations
- Sector
- SGC Consumer Discretionary
- NKTR Health Care
- Exchange
- SGC Nasdaq
- NKTR Nasdaq
- Market Cap
- SGC 215.7M
- NKTR 948.8M
- IPO Year
- SGC N/A
- NKTR 1994
- Fundamental
- Price
- SGC $11.47
- NKTR $51.07
- Analyst Decision
- SGC Strong Buy
- NKTR Strong Buy
- Analyst Count
- SGC 3
- NKTR 6
- Target Price
- SGC $17.33
- NKTR $81.67
- AVG Volume (30 Days)
- SGC 37.1K
- NKTR 1.2M
- Earning Date
- SGC 11-05-2025
- NKTR 11-06-2025
- Dividend Yield
- SGC 4.86%
- NKTR N/A
- EPS Growth
- SGC N/A
- NKTR N/A
- EPS
- SGC 0.52
- NKTR N/A
- Revenue
- SGC $576,240,000.00
- NKTR $74,934,000.00
- Revenue This Year
- SGC $1.46
- NKTR N/A
- Revenue Next Year
- SGC $3.32
- NKTR N/A
- P/E Ratio
- SGC $22.10
- NKTR N/A
- Revenue Growth
- SGC 4.03
- NKTR N/A
- 52 Week Low
- SGC $9.11
- NKTR $6.48
- 52 Week High
- SGC $18.48
- NKTR $52.75
- Technical
- Relative Strength Index (RSI)
- SGC 44.06
- NKTR 85.95
- Support Level
- SGC $11.02
- NKTR $42.12
- Resistance Level
- SGC $12.27
- NKTR $50.53
- Average True Range (ATR)
- SGC 0.51
- NKTR 3.47
- MACD
- SGC -0.22
- NKTR 1.32
- Stochastic Oscillator
- SGC 16.30
- NKTR 93.25
About SGC Superior Group of Companies Inc.
Superior Group Of Companies Inc designs apparel products. The company's operating segment includes Branded Products; Healthcare Apparel and Contact Centers. It generates maximum revenue from the Branded Products segment. The Branded Products segment produce and sell customized merchandising solutions, promotional products and branded uniform programs to customers.
About NKTR Nektar Therapeutics
Nektar Therapeutics is a clinical-stage, research-based drug discovery biopharmaceutical company focused on discovering and developing medicines in the field of immunotherapy. The company is focused on discovering and developing medicines in the field of immunotherapy. Its pipeline products are REZPEG (NKTR-358), REZPEG (NKTR-358), REZPEG (NKTR-358), NKTR-422, NKTR-0165, NKTR-255, and Others.